Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies. - Ferrari M; Parekh F; Maciocia P; Horna P; Thomas S; Sewell AK; Pule M (Nature communications, 2025)